Literature DB >> 15967637

Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.

Olivia Cochet1, Catherine Frelin, Jean-François Peyron, Véronique Imbert.   

Abstract

Survival and proliferation of Hodgkin lymphoma (HL) cells are influenced by many cytokines produced by different cell types in the lymph node microenvironment. STAT, family of transcription factors, are key mediators of cytokine signaling and their perturbation contributes to various human diseases. Electrophoretic mobility shift and phosphoprotein immunoblotting analyses were used to study STAT activation in HL cell lines. We thus observed high levels of constitutively activated STAT1, 3, 5 and 6 in HDLM-2 and L540 cells, which could be correlated with JAK kinase activation. In contrast KM-H2 cells did not display STAT activation. Preventing constitutive STAT activation by specific JAK kinases inhibitors induced apoptosis of HL cell lines and was associated with a strong decrease in the expression of the anti-apoptotic genes IAP-1, IAP-2, Bcl-xL, Bfl1 and Traf1. Silencing of JAKs by specific siRNAs also induced apoptosis of HL cells. Altogether, these results suggest that aberrant STAT activation in Hodgkin cells may promote cell survival and as a consequence facilitate oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967637     DOI: 10.1016/j.cellsig.2005.05.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  18 in total

Review 1.  Genomic alterations in Hodgkin's lymphoma.

Authors:  Marc A Weniger; Thomas F E Barth; Peter Möller
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

2.  A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.

Authors:  Byung Hak Kim; Chang-Hong Yin; Qianxu Guo; Erika A Bach; Haeryun Lee; Claudio Sandoval; Somasundaram Jayabose; Agnieszka Ulaczyk-Lesanko; Dennis G Hall; Gyeong-Hun Baeg
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.

Authors:  Daniela Buglio; Georgios V Georgakis; Shino Hanabuchi; Kazuhiko Arima; Noor M Khaskhely; Yong-Jun Liu; Anas Younes
Journal:  Blood       Date:  2008-06-09       Impact factor: 22.113

4.  Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.

Authors:  Wei Ju; Meili Zhang; Kelli M Wilson; Michael N Petrus; Richard N Bamford; Xiaohu Zhang; Rajarshi Guha; Marc Ferrer; Craig J Thomas; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 5.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

6.  The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma.

Authors:  E Derenzini; M Lemoine; D Buglio; H Katayama; Y Ji; R E Davis; S Sen; A Younes
Journal:  Blood Cancer J       Date:  2011-12-02       Impact factor: 11.037

7.  HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells.

Authors:  Nils Schoof; Frederike von Bonin; Lorenz Trümper; Dieter Kube
Journal:  Cell Commun Signal       Date:  2009-07-16       Impact factor: 5.712

8.  Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Authors:  Shyamesh Kumar; Joram J Buza; Shane C Burgess
Journal:  Cancer Microenviron       Date:  2009-03-18

9.  Androgen receptor-target genes in african american prostate cancer disparities.

Authors:  Bi-Dar Wang; Qi Yang; Kristin Ceniccola; Fernando Bianco; Ramez Andrawis; Thomas Jarrett; Harold Frazier; Steven R Patierno; Norman H Lee
Journal:  Prostate Cancer       Date:  2013-01-10

10.  Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.

Authors:  Faisal M Fadlelmola; Minglong Zhou; Ronald J de Leeuw; Nirpjit S Dosanjh; Karynn Harmer; David Huntsman; Wan L Lam; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2008-01-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.